News
Ehlers, MD, shares results from the phase 1 HELIOS study investigating OTX-TKI for the treatment of nonproliferative diabetic retinopathy. The study examined a single injection of OTX-TKI ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback